首页> 外文期刊>The Turkish journal of pediatrics >Is basal serum 17-OH progesterone a reliable parameter to predict nonclassical congenital adrenal hyperplasia in premature adrenarche?
【24h】

Is basal serum 17-OH progesterone a reliable parameter to predict nonclassical congenital adrenal hyperplasia in premature adrenarche?

机译:基础血清17-OH孕酮是否是预测早产肾上腺原发性非经典先天性肾上腺增生的可靠参数?

获取原文
获取原文并翻译 | 示例
           

摘要

To determine the critical features for the diagnosis of nonclassical 21 hydroxylase deficiency (NC210HD) without performing adrenocorticotropic hormone (ACTH) test, we studied 186 cases with premature adrenarche. Clinical and laboratory features as well as basal 17-hydroxyprogesterone (17-OHP) were analyzed to determine factors important for differentiating NC21OHD. Overall, 6 patients (3.2%) had ACTH-stimulated 17-OHP > 10 ng/ml. A cutoff level of 2 ng/ml for basal 17-OHP was 66.7% sensitive and 78% specific for NC21OHD; however, a cutoff level of 1.55 ng/ml had higher sensitivity (83%) and specificity (70.6%). A cutoff of 1.55 ng/ml would lead to 31% of cases with premature adrenarche having to undergo ACTH test, and only one case would have been missed. That case had a bone age SDS > 2. Three cases out of five with a basal 17-OHP > 5 ng/ml had stimulated 17-OHP < 10 ng/ml. A cutoff of 1.55 ng/ml for basal 17-OHP together with bone SDS > 2 in those with lower basal levels as a guide for carrying out an ACTH test may yield better results in the diagnosis of NC21OHD in the premature adrenarche population. A cutoff of 5 ng/ml for basal 17-OHP should not be used for diagnosis of NC21OHD.
机译:为了确定在不进行促肾上腺皮质激素(ACTH)测试的情况下诊断非经典21型羟化酶缺乏症(NC210HD)的关键特征,我们研究了186例肾上腺皮质过早的患者。分析临床和实验室特征以及基础17-羟基孕酮(17-OHP),以确定对于区分NC21OHD重要的因素。总体而言,有6名患者(3.2%)接受了ACTH刺激的17-OHP> 10 ng / ml。基础17-OHP的截断水平为2 ng / ml,对NC21OHD敏感度为66.7%,特异度为78%。然而,1.55 ng / ml的临界值具有更高的灵敏度(83%)和特异性(70.6%)。 1.55 ng / ml的临界值将导致31%的肾上腺功能过早的病例必须接受ACTH测试,而只有1例会漏诊。该病例的骨龄SDS>2。五分之三的基础17-OHP> 5 ng / ml刺激17-OHP <10 ng / ml。在基线水平较低的人群中,基线17-OHP的临界值1.55 ng / ml以及骨SDS> 2的临界值,作为进行ACTH测试的指南,可能会在肾上腺早熟人群的NC21OHD诊断中产生更好的结果。基线17-OHP的临界值为5 ng / ml不应用于诊断NC21OHD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号